ERCC1 expression predicts treatment response and survival in advanced uterine cervical cancer patients treated with platinum-based chemotherapy

被引:0
|
作者
Baek, S. W. [1 ]
Choi, Y. S. [1 ]
Song, I. C. [1 ]
Yun, H. J. [1 ]
Jo, D. Y. [1 ]
Kim, S. Y. [1 ]
Lee, H. J. [1 ]
机构
[1] Chungnam Natl Univ Hosp, Intenal Med, Daejeon, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
274P
引用
收藏
页码:81 / 82
页数:2
相关论文
共 50 条
  • [1] ERCC1 expression status predicts the response and survival of patients with metastatic or recurrent cervical cancer treated via platinum-based chemotherapy
    Ryu, Hyewon
    Song, Ik-Chan
    Choi, Yoon-Seok
    Yun, Hwan-Jung
    Jo, Deog-Yeon
    Kim, Jin Man
    Ko, Young Bok
    Lee, Hyo Jin
    MEDICINE, 2017, 96 (51)
  • [2] Expression of ERCC1 protein in biopsy specimen predicts survival in advanced ovarian cancer patients treated with platinum-based chemotherapy
    Milovic-Kovacevic, M.
    Srdic-Rajic, T.
    Radulovic, S.
    Bjelogrlic, S.
    Gavrilovic, D.
    JOURNAL OF BUON, 2011, 16 (04): : 708 - 714
  • [3] ERCC1 polymorphisms in patients with advanced bladder cancer treated with platinum-based chemotherapy
    Bamias, A.
    Nikitas, N.
    Karadimou, A.
    Gika, D.
    Karavasilis, V.
    Briasoulis, E. C.
    Chrisofos, M.
    Murray, S.
    Pectasides, D. G.
    Dimopoulos, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] ERCC1 expression in metastatic triple negative breast cancer patients treated with platinum-based chemotherapy
    El Baiomy, M.
    El Kashef, W.
    El Zafarany, M.
    BREAST, 2017, 32 : S92 - S92
  • [5] The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer
    Song, Wenhui
    Ma, Hongshun
    ONCOTARGETS AND THERAPY, 2016, 9 : 3465 - 3471
  • [6] ERCC1 Expression Predicts Response and Survival in Locally Advanced Cervical Carcinoma Patients Treated With Concurrent Chemoradiotherapy
    Lee, H. J.
    Liang, Z. L.
    Song, E. K.
    Yun, H. J.
    Kim, S.
    Jo, D. Y.
    Kim, J. M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S540 - S540
  • [7] Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy
    Sodja, Eva
    Knez, Lea
    Kern, Izidor
    Ovcaricek, Tanja
    Sadikov, Aleksander
    Cufer, Tanja
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (18) : 3378 - 3385
  • [8] Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy
    Ozcan, Muhammet Fuat
    Dizdar, Omer
    Dincer, Nazmiye
    Balci, Serdar
    Guler, Gulnur
    Gok, Bahri
    Pektas, Gokhan
    Seker, Mehmet Metin
    Aksoy, Sercan
    Arslan, Cagatay
    Yalcin, Suayib
    Balbay, Mevlana Derya
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (08) : 1709 - 1715
  • [9] The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis
    Wei, Kong-Kong
    Jiang, Lei
    Wei, Yao-Yao
    Wang, Yu-Feng
    Qian, Xuan-Kun
    Dai, Qiang
    Guan, Quan-Lin
    TUMOR BIOLOGY, 2014, 35 (09) : 8721 - 8731
  • [10] ERCC1 Expression as a Predictor of Resistance to Platinum-based Chemotherapy in Primary Ovarian Cancer
    Muallem, Mustafa Zelal
    Braicu, Ioana
    Nassir, Mani
    Richter, Rolf
    Sehouli, Jalid
    Arsenic, Ruza
    ANTICANCER RESEARCH, 2014, 34 (1A) : 393 - 399